NCT00000479View on ClinicalTrials.gov

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

39,876

Participants

Timeline

Start Date

September 30, 1992

Primary Completion Date

March 31, 2004

Study Completion Date

February 28, 2005

Conditions
Cardiovascular DiseasesCerebrovascular DisordersCoronary DiseaseHeart DiseasesMyocardial InfarctionMyocardial IschemiaVascular Diseases
Interventions
DRUG

Aspirin

Participants will receive 100 mg of aspirin every other day.

DRUG

Vitamin E

Participants will receive 600 IU of vitamin E every other day.

BEHAVIORAL

Placebo

Participants will receive placebo.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT00000479 - Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | Biotech Hunter | Biotech Hunter